supported by grants from the National Basic Research Program of China (973 Program), No. 2012CB967900, 2012CB967904;the National Natural Science Foundation of China, No. 81070782;the Natural Science Foundation of Zhejiang Province, China, No. 30672308;the Qianjiang Talent Project of Science and Technology Ministry in Zhejiang Province, No. 2011R10014;the Natural Science Foundation of Ningbo, No. 2011A610042
Lentivirus carrying the Atohl gene can infect Corti's organ and express a hair-like cell surface marker in the supporting cell area. However, expression of the gene carried by adenovirus is instantaneous, which undou...
supported financially by the National Basic Research Program of China(973 Program)(Nos. 2009CB918702 and 2012CB825504);the National Natural Science Foundation of China(Nos.31201007,31271573 and 31071087)
Precise modifications of complex genomes at the single nucleotide level have been one of the big goals for scientists working in basic and applied genetics,including biotechnology,drug development,gene therapy and syn...
supported by a grant from the Major State Basic Research Development Program of China (973 Program) (No. 2002CB513100)
This study examined the effect of small interfering RNA-mediated β-catenin knockdown on the survival,invasion and chemosensitivity of human osteosarcoma cells(U2-OS cells).The siRNA against β-catenin was construct...
supported by the Distinguished Young Scholars(No.50888001);National Natural Science Foundation of China(No.21090352);National Basic Research Program(973 Program,2009CB526403);Program for Changjiang Scholars and Innovative Research Team in University of China and Fundamental Research Funds for Central Universities(No.2010QNA4022)
Gene therapy has emerged as a potential new approach to treat genetic disorders by delivering therapeutic genes to target diseased tissues. However, its clinical use has been impeded by gene delivery systems. The vira...
Supported by the Major State Basic Research Development Program (973 Program) of China, No. 2003CB515507
AIM: To develop a conditionally replicative gene-viral vector system called CNHK500-p53, which contains dual promoters within the E1 region, and combines the advantages of oncolytic virus and gene therapies for hepat...